Nationwide Fund Advisors’s CorMedix CRMD Stock Holding History

Nationwide Fund Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,029	Closed	-$53K	–	3271
2016 Q1	$53K	Hold	4,029	–	–	﹤0.01%	2974
2015 Q4	$41K	Hold	4,029	–	–	﹤0.01%	3014
2015 Q3	$40K	Hold	4,029	–	–	﹤0.01%	3054
2015 Q2	$78K	Buy	+4,029	New	+$138K	﹤0.01%	3056

Other funds holding CRMD

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

GLRA

Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Nationwide Fund Advisors's CRMD Position: Q2 2016 in Review

Nationwide Fund Advisors sold out of CorMedix (CRMD) in Q2 2016, closing a stake of 4,029 shares — an estimated $53K sold.

Nationwide Fund Advisors first reported a position in CRMD in Q2 2015 and held it in 4 quarters. The position peaked at $78K in Q2 2015. 47 funds tracked by Wall St. Rank hold CRMD as of Q2 2016.

Nationwide Fund Advisors reported no remaining CorMedix position as of Q2 2016 after selling out during the quarter.
Nationwide Fund Advisors sold 4,029 CorMedix shares in Q2 2016, an estimated $53K.
Nationwide Fund Advisors first reported a position in CorMedix in Q2 2015 and held it in 4 quarters.
Nationwide Fund Advisors's CorMedix position peaked at $78K in Q2 2015.
47 funds tracked by Wall St. Rank held CorMedix as of Q2 2016.

Based on Nationwide Fund Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.